Patents by Inventor Rene Alvaro Segura Velazquez

Rene Alvaro Segura Velazquez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11020449
    Abstract: The present invention refers to the use of the peptide defined by the amino acid sequence G-Y-Y-Y-P-S-D-P-N-T-F-Y-A-P-P-Y-S-A, named GK-1, to be used as an antitumor and antimetastatic agent or for the treatment of cancer, specifically of basal cell carcinoma, squamous cell carcinoma, transitional cell carcinoma, and adenocarcinoma, and preferably for the treatment of breast cancer.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: June 1, 2021
    Assignee: UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO
    Inventors: Edda Lydia Sciutto Conde, Gladis del Carmen Fragoso Gonzalez, Diana Torres Garcia, Jacquelynne Brenda Cervantes Torres, Rene Alvaro Segura Velazquez, Armando Perez Torres, Karen Manucharyan
  • Publication number: 20200222495
    Abstract: The present invention refers to the use of the peptide defined by the amino acid sequence G-Y-Y-Y-P-S-D-P-N-T-F-Y-A-P-P-Y-S-A, named GK-1, to be used as an antitumor and antimetastatic agent or for the treatment of cancer, specifically of basal cell carcinoma, squamous cell carcinoma, transitional cell carcinoma, and adenocarcinoma, and preferably for the treatment of breast cancer.
    Type: Application
    Filed: May 18, 2017
    Publication date: July 16, 2020
    Inventors: Edda Lydia Sciutto Conde, Gladis del Carmen Fragoso Gonzalez, Diana Torres Garcia, Jacquelynne Brenda Cervantes Torres, Rene Alvaro Segura Velazquez, Armando Perez Torres, Karen Manucharyan
  • Patent number: 9446122
    Abstract: The present invention is directed to the use of FGK-1 immunopotentiator, composed by the peptide named GK-1, characterized by the sequence G-Y-Y-Y-P-S-D-P-N-T-F-Y-A-P-P-Y-S-A (SEQ ID No. 1) and linked to the pVIII surface protein of M13 filamentous phage, to prepare pharmaceutical products potentiating the protective immune response of vaccine antigens when used by itself or conjointly with these antigens administered either intranasally, subcutaneously, or intramuscularly, yielding an increase in the level of specific antibodies against vaccine antigens in serum and in bronchioalveolar lavages.
    Type: Grant
    Filed: July 28, 2012
    Date of Patent: September 20, 2016
    Assignee: UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO
    Inventors: Edda Lydia Sciutto Conde, Gladis del Carmen Fragoso Gonzalez, René Alvaro Segura Velázquez, Jacquelynne Brenda Cervantes Torres, Karen Manucharyan, Abel Blancas Cabrera, Rutilia Marisela Hernandez Gonzales
  • Publication number: 20140302085
    Abstract: The present invention is directed to the use of FGK-1 immunopotentiator, composed by the peptide named GK-1, characterized by the sequence G-Y-Y-Y-P-S-D-P-N-T-F-Y-A-P-P-Y-S-A and linked to the pVIII surface protein of M13 filamentous phage, to prepare pharmaceutical products potentiating the protective immune response of vaccine antigens when used by itself or conjointly with these antigens administered either intranasally, subcutaneously, or intramuscularly, yielding an increase in the level of specific antibodies against vaccine antigens in serum and in bronchoalveolar lavages.
    Type: Application
    Filed: July 28, 2012
    Publication date: October 9, 2014
    Applicant: UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO
    Inventors: Edda Lydia Sciutto Conde, Gladis del Carmen Fragoso Gonzalez, René Alvaro Segura Velázquez, Jacquelynne Brenda Cervantes Torres, Karen Manucharyan, Abel Blanca Cabrera, Rutilia Marisela Hernandez Gonzalez